Agenda
ExciPerience 2022 is over!
Agenda 2022
Timezone: Central European Time
| 1. Day | March 09 - Session 1 | March 09 - Session 2 | 2. Day | March 10 - Session 1 | March 10 - Session 2 |
|---|---|---|---|---|---|
| 12:00 - 13:00 CET | A.I. enhanced networking carousel | 12:00 - 12:15 CET | Introduction Philippe Tschopp |
||
| 13:00 - 13:15 | Welcome message and overview Philippe Tschopp | 12:15 - 13:00 | The role of 3D printing in treatments for rare diseases Prof. Simon Gaisford | Early Phase Pharmaceutical Product Development using Quality by Design tools Prof. Walkiria Schlindwein |
|
| 13:15 - 14:00 | Opportunity and challenge of artificial intelligence (AI) in drug delivery Prof. Defang Ouyang | Biopharmaceutical Implications of Excipient Variability on Drug Solubility and Dissolution Dr Nikoletta Fotaki | 13:00 - 14:00 | Sex matters: Excipients actively modulate drug response differently in males and females Christine Madla, PhD | Formulation trends, including Continuous Manufacturing tableting Dr Maj-Britt Cepok The Developability Classification System for Poorly Soluble Drug Formulation Strategies Dr Gudrun Birk |
| 14:00 - 15:00 | In-silico polymer screenings for rational amorphous solid dispersion development Dr Christian Lübbert Polymers and API crystallization: from controlling form and habit to ASD Dr Dan Dumitrescu | Pulmonary Delivery of siRNA as Antiviral Treatment of SARS-CoV-2 Infections Prof. Olivia Merkel | 14:00 - 15:00 | A.I. enhanced networking carousel | Excipient innovation presentations in lobby and exhibitor booths |
| 15:00 - 16:00 | A.I. enhanced networking carousel | Excipient innovation presentations in lobby and exhibitor booths | 15:00 - 16:00 | Start-Up speeches: Microneedle Device: Promise Effective Oral Delivery of Biologics Dr Anat Raz Amorphous Formulation of Poorly Soluble Drugs in Mesoporous Magnesium Carbonate Dr Jonas Fagerberg | DC-lactoses: cornerstones for reliable continuous manufacturing processes Dr Sonja Bauhuber Key advantages using sugar spheres in multiparticulate oral drug delivery Dr Philipp Werner Enabling Novel Pharmaceutical Therapies through 3D-printing Kyle Smith |
| 16:00 - 17:00 | Numerical methods in the design of solid pharmaceutical formulations: state of the art, and future challenges Dr Maxim Puchkov | Formulations for infants and young children: Innovative use of excipients in film coating Dr Fang Liu | 16:00 - 17:00 | Application of lipids in challenging processes: Spray-drying and 3D printing Dr Sharareh Salar-Behzadi | The complexities of Excipient Registration in China and potential solutions Dave Schoneker |
| 17:00 - 18:00 | Tumor neurons and patient sex affect nanomedicine efficacy Prof. Avi Schroeder | Phospholipids as bioactive excipients in the treatment of liver fibrosis Prof. Paola Luciani | 17:00 - 18:00 | Speeches on titanium dioxide (TiO2): TiO2 free film coating formulations - technical aspects Dr Mahmud Yunis The EFSA Opinion of E171: A TDMA Perspective Dr David Lockley Potential Global Regulatory Impact of the EU E171 Ban on Dietary Supplements and Pharmaceuticals Dave Schoneker |
|
| 18:00 - 19:00 | Keynote: How 3D printing is changing medicine Prof. Joseph DeSimone | 18:00 - 19:00 | Experts panel on titanium dioxide (TiO2) | ||
| 19:00 - 20:00 | Lounge area networking | 19:00 - 20:00 | Lounge area networking | ||